Adverse drug reactions (ADRs) are a leading cause of morbidity and mortalit
y, with the highest incidence occurring in patients age 60 and older. Presc
ribing the lowest effective doses of medications to older patients can help
avoid ADRs, minimize bothersome side effects, and increase rates of compli
ance. For many drugs, clinical experience and published studies demonstrate
the effectiveness of doses substantially lower than those recommended in s
tandard references. This article examines the problem of ADRs in older pati
ents, discusses pharmacokinetic data regarding older versus younger adults,
and provides effective lower doses for many common drugs.